Where Passion Meets Purpose
A
s part of the 2017-2022 Strategic Plan, Nationwide Children's Hospital committed to Best Outcomes for all children. This commitment includes developing cures for rare diseases and a better understanding of the treatment of genetic conditions in children. Genomics is one of the areas of focus
Lee Ann Wallace that we believe will accelerate our MBA, BSN, RN, NEA-BC Journey to Best Outcomes. At the Abigail Senior Vice President, Patient Care Services, Chief Nursing Officer
Wexner Research Institute at Nationwide Children’s Hospital, our world-renowned research teams are breaking new ground in genomics, gene therapy, and tissue engineering. This research will provide transformational work in understanding the genetic causes of disease, an ability to more rapidly sequence genomes, as well as reducing the cost of this state-ofthe-art medical science and technology. Rather than a one size fits all approach, individualized treatment care plans can be developed using high precision diagnostics. Large research studies are taking place on the identification of cancer tumor DNA while understanding what processes cause a normal cell to
become a cancer cell. Developing a better understanding of the cancer location and causes of these over-expressed genes, we will increase our successful outcomes for cancer therapies. The ability to translate their research into treatment using whole-exome sequencing allowing for diagnosis of pediatric conditions that traditional tests and investigation would not be able to identify. Through genome sequencing, targeted therapies, and medications based on the identification of genetic errors will be developed, all leading to improved outcomes.
The Steve and Cindy Rasmussen Institute for Genomic Medicine: An Overview Richard K. Wilson, PhD, Executive Director, The Steve and Cindy Rasmussen Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children’s Hospital Elaine R. Mardis, PhD, Co-executive Director, The Steve and Cindy Rasmussen Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children’s Hospital
While work has been focused on rare genetic conditions and cancer, the future is wide open. Other areas of future expansion include diagnosis and treatment of seizure disorders and the ability for rapid identification of neonatal conditions. As care team providers, we need to continue to expand our knowledge and understanding of genomics in our own areas of practice, while identifying the impact of these discoveries on our patients and their families.
2017-2022
JOURNEY TO BEST OUTCOMES VISION
BEST OUTCOMES
GOAL Pre-eminent Clinical & Research Programs
One Team Values
for Kids Everywhere
CORE STRATEGIES Operational Excellence
Growth & Partnerships Education
4 | IN PATIENT CARE
ACCELERATORS Quality, Safety & Service
Behavioral Health
Genomics
Wellness/ Population Health
IN PATIENT CARE | 5
